Roland Landman

2.1k total citations
63 papers, 917 citations indexed

About

Roland Landman is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Roland Landman has authored 63 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Infectious Diseases, 44 papers in Virology and 13 papers in Epidemiology. Recurrent topics in Roland Landman's work include HIV/AIDS drug development and treatment (48 papers), HIV Research and Treatment (44 papers) and HIV/AIDS Research and Interventions (38 papers). Roland Landman is often cited by papers focused on HIV/AIDS drug development and treatment (48 papers), HIV Research and Treatment (44 papers) and HIV/AIDS Research and Interventions (38 papers). Roland Landman collaborates with scholars based in France, Senegal and Martinique. Roland Landman's co-authors include Pierre‐Marie Girard, Gilles Peytavin, Éric Delaporte, Yazdan Yazdanpanah, Souleymane Mboup, Diane Descamps, Françoise Brun‐Vézinet, Papa Salif Sow, Charlotte Charpentier and José M. Gatell and has published in prestigious journals such as The Lancet, PLoS ONE and Journal of Virology.

In The Last Decade

Roland Landman

60 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roland Landman France 16 815 541 242 152 42 63 917
James Stanford United States 8 955 1.2× 711 1.3× 286 1.2× 186 1.2× 50 1.2× 9 1.1k
Edmund Wilkins United Kingdom 13 604 0.7× 443 0.8× 154 0.6× 305 2.0× 41 1.0× 24 777
Olayemi Osiyemi United States 16 762 0.9× 478 0.9× 187 0.8× 285 1.9× 47 1.1× 37 879
Paula Britto United States 15 719 0.9× 526 1.0× 199 0.8× 170 1.1× 11 0.3× 25 828
U. Fritz Bredeek United States 9 546 0.7× 280 0.5× 256 1.1× 134 0.9× 16 0.4× 11 609
Mauro Moroni Italy 8 433 0.5× 272 0.5× 198 0.8× 139 0.9× 22 0.5× 10 660
Maura Laverty United States 8 356 0.4× 243 0.4× 181 0.7× 59 0.4× 53 1.3× 15 517
Suteeraporn Pinyakorn Thailand 17 889 1.1× 847 1.6× 338 1.4× 373 2.5× 79 1.9× 58 1.3k
Vadim Pokrovskiy Russia 6 754 0.9× 563 1.0× 146 0.6× 296 1.9× 50 1.2× 13 828
Sharon M. Seifert United States 11 476 0.6× 242 0.4× 209 0.9× 80 0.5× 27 0.6× 15 538

Countries citing papers authored by Roland Landman

Since Specialization
Citations

This map shows the geographic impact of Roland Landman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Landman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Landman more than expected).

Fields of papers citing papers by Roland Landman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Landman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Landman. The network helps show where Roland Landman may publish in the future.

Co-authorship network of co-authors of Roland Landman

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Landman. A scholar is included among the top collaborators of Roland Landman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Landman. Roland Landman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serris, Alexandra, Valentine Marie Ferré, Quentin Le Hingrat, et al.. (2024). Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 results. Journal of Antimicrobial Chemotherapy. 79(11). 2932–2938. 6 indexed citations
2.
Bachelard, Antoine, Aurélie Sautereau, Valentina Isernia, et al.. (2022). Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1. International Journal of Infectious Diseases. 122. 152–154. 8 indexed citations
3.
Ghosn, Jade, Lambert Assoumou, Caroline Lascoux‐Combe, et al.. (2021). HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 Infection. The Journal of Infectious Diseases. 225(1). 116–120. 4 indexed citations
4.
Parisey, Marion, Françoise Louni, Élisabeth Bouvet, et al.. (2019). HIV Infection in North African Patients. AIDS Research and Human Retroviruses. 35(7). 628–633. 1 indexed citations
5.
Gantner, Pierre, Laurence Morand‐Joubert, Pierre Frange, et al.. (2019). “Real life” use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study. PLoS ONE. 14(4). e0216010–e0216010. 2 indexed citations
6.
Fournier, Anna, Yazdan Yazdanpanah, Renaud Verdon, et al.. (2019). Incidence of and risk factors for medical care interruption in people living with HIV in recent years. PLoS ONE. 14(3). e0213526–e0213526. 7 indexed citations
7.
Perrier, Marine, Charlotte Charpentier, Gilles Peytavin, et al.. (2017). Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort. Journal of Antimicrobial Chemotherapy. 72(6). 1745–1751. 7 indexed citations
8.
Perrier, Marine, Benoît Visseaux, Roland Landman, et al.. (2017). No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir. Journal of Antimicrobial Chemotherapy. 73(1). 173–176. 9 indexed citations
9.
10.
Charpentier, Charlotte, Minh Lê, Véronique Joly, et al.. (2015). Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up. PLoS ONE. 10(7). e0134430–e0134430. 3 indexed citations
11.
Charpentier, C., Lucile Larrouy, Benoît Visseaux, et al.. (2012). Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients. Journal of Antimicrobial Chemotherapy. 67(6). 1459–1461. 20 indexed citations
12.
Larrouy, Lucile, Charlotte Charpentier, Roland Landman, et al.. (2011). Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen. AIDS. 25(17). 2143–2148. 2 indexed citations
13.
Beaudrap, Pierre De, Roland Landman, Ndèye Fatou Ngom Gueye, et al.. (2010). Changes in the Renal Function After Tenofovir-Containing Antiretroviral Therapy Initiation in a Senegalese Cohort (ANRS 1215). AIDS Research and Human Retroviruses. 26(11). 1221–1227. 27 indexed citations
14.
Rockstroh, Jürgen K., José M. Gatell, Roland Landman, & Andrea Antinori. (2010). Management of Late-presenting Patients with HIV Infection. Antiviral Therapy. 15(1_suppl). 25–30. 14 indexed citations
15.
Landman, Roland, et al.. (2009). Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients. AIDS. 23(3). 426–428. 12 indexed citations
16.
Beaudrap, Pierre De, et al.. (2008). Long-Term Efficacy and Tolerance of Efavirenz- and Nevirapine-Containing Regimens in Adult HIV Type 1 Senegalese Patients. AIDS Research and Human Retroviruses. 24(6). 753–760. 19 indexed citations
17.
Johnson, Margaret, Andrzej Horban, Keikawus Arastéh, et al.. (2005). Comparison of gastrointestinal tolerability and patient preference for treatment with the 625 mg and 250 mg nelfinavir tablet formulations. HIV Medicine. 6(2). 107–113. 30 indexed citations
18.
Levacher, M., F. Bouscarat, Roland Landman, et al.. (2000). Frequency of Cytokine-Producing T Cells in HIV-Infected Patients Treated with Stavudine, Didanosine, and Ritonavir. AIDS Research and Human Retroviruses. 16(17). 1869–1875. 6 indexed citations
19.
Landman, Roland, et al.. (1991). [Which compressor should be used to deliver pentamidine aerosols with the Respirgard II?].. PubMed. 8(4). 391–5. 1 indexed citations
20.
Girard, Pierre‐Marie, C. Gaudebout, Françoise Camus, et al.. (1989). PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA RELAPSE BY PENTAMIDINE AEROSOL IN ZIDOVUDINE-TREATED AIDS PATIENTS. The Lancet. 333(8651). 1348–1353. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Stanford Breakdown of academic impact, for papers by Edmund Wilkins Breakdown of academic impact, for papers by Olayemi Osiyemi Breakdown of academic impact, for papers by Paula Britto Breakdown of academic impact, for papers by U. Fritz Bredeek Breakdown of academic impact, for papers by Mauro Moroni Breakdown of academic impact, for papers by Maura Laverty Breakdown of academic impact, for papers by Suteeraporn Pinyakorn Breakdown of academic impact, for papers by Vadim Pokrovskiy Breakdown of academic impact, for papers by Sharon M. Seifert
Rankless by CCL
2026